Digital therapeutics will gain wider adoption and reimbursement in the year ahead. That was the conclusion of a new analysis – Digital Health 2026: Ten Predictions As The Industry Shifts From Hype To Hardwiring. The analysts spoke of how digital treatment adoption in 2026 has shifted from passive consumer app usage to “hardwired” clinical workflows. And in 2027, they predict evidence-based software treatments for mental health, pain, insomnia, and related conditions will increasingly be prescribed like medications, with broader payer coverage.

Market interest in digital treatment remains strong. There are 552 firms with digital therapeutic offerings that have raised $7.7 billion across 998 funding rounds. And over the past 12 months alone, investments topped $1.1 billion across…